A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: Associations with febrile illness, parasitemia, and anemia

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 2, 1998, Pages 211-219

  Branch, Oralee H ^a   Udhayakumar, Venkatachalam ^a   Hightower, Allen W ^a   Oloo, Aggrey J ^a   Hawley, William A ^a   Nahlen, Bernard L ^a   Bloland, Peter B ^a   Kaslow, David C ^a   Lal, Altaf A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MALARIA VACCINE; MEMBRANE PROTEIN; PROTOZOAL PROTEIN;

ADULT; ANEMIA; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEROZOITE; PARASITEMIA; PLASMODIUM FALCIPARUM; PREGNANCY; PROTEIN DOMAIN;

EID: 0031906086     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.211     Document Type: Article

References (27)

1. Nussenzeig RS, Long CA, 1994. Malaria vaccines: multiple targets. Science 265: 1381-1383.
2. Holder AA, 1994. Proteins on the surface of the malaria parasite and cell invasion. Parasitology 108: S5-S15.
3. Blackman M, Heidrich H-G, Donachie S, McBride JS, Holder AA, 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion inhibiting antibodies. J Exp Med 172: 379-392.
4. Blackman MJ, Ling IT, Nicholls SC, Holder AA, 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol 49: 29-34.
5. Egan AF, Chappell JA, Burghaus PA, Morris JS, McBride JS, Holder AA, Kaslow DC, Riley EM, 1995. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP-1 (19 kDa), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun 63: 456-466.
6. Brown GV, Anders RF, Mitchell GF, 1992. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro. Nature 297: 591-593.
7. Chappel JA, Holder AA, 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein1. Mol Biochem Parasitol 60: 303-312.
8. Chang SP, Gibson HL, Lee-Ng CT, Barr PJ, Hui GSN, 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol 149: 548-555.
9. Cooper JA, Cooper LT, Saul AJ, 1992. Mapping of the region predominantly recognized by antibodies to Plasmodium falciparum merozoite surface antigen MSA 1. Mol Biochem Parasitol 51: 301-312.
10. Hui GSN, Hashiro C, Nikaido C, Case SE, Hashimoto A, Gibson H, Barr PJ, Chang SP, 1993. Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein expressed in baculovirus. Infect Immun 61: 3403-3411.
11. Pirson PJ, Perkins ME, 1985. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J Immunol 134: 1946-1951.
12. Blackman MJ, Scott-Finnegan T, Shati S, Holder AA, 1994. Antibodies inhibit the protease mediated processing of a malaria merozoite surface protein. J Exp Med 180: 389-393.
13. Burns JM, Parke LA, Daley TM, Cavacini LA, Weidanz WP, Long CA, 1989. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent parasite Plasmodium yoelii. J Immunol 142: 2835-2840.
14. Long CA, Daly TM, 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 155: 236-243.
15. Kumar SA, Yadava D, Keister DB, Tian JH, Ohi M, Perdue-Greenfield KA, Mille LH, Kaslow DC, 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol Med 1: 325-332.
16. Riley EM, Allen SJ, Wheeler JG, Blackman MJ, Bennett S, Takacs B, Schonfeld H-A, Holder AA, Greenwood BM, 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSPl) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol 14: 321-337.
17. Tolle R, Fruh K, Doumbo O, Koita O, N'Diaye M, Fischer A, Dretz K, Bujard H, 1993. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp 190 and control of malarial infections. Infect Immun 61: 40-47.
18. Udhayakumar V, Anyona D, Kariuki S, Shi YP, Bloland PB, Branch OH, Weiss W, Nahlen BL, Kaslow DC, Lal AA, 1995. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kD domain of the Plasmodium falciparum merozoite surface protein (MSP)-l. J Immunol 154: 6022-6030.
19. Al-Yaman F, Genton B, Kramer K, Chang S, Hui G, Baisor M, Alpers M, 1996. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg 54: 443-448.
20. Beier JC, Perkins PV, Onyango FK, Gargan TP, Oster CN, Whitmire RE, Koech DK, Roberts CR, 1990. Characterization of malaria transmission by Anopheles (Diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol 27: 570-574.
21. 19kD) variants secreted from Saccharomyces cerevisiae. Mol Biochem Parasitol 63: 283-285.
22. SAS Institute, Inc., 1985. SAS User's Guide: Statistics. Version 5. Cary NC: SAS Institute Inc.
23. 19) recognized by human antibodies. Parasite Immunol 17: 269-275.
24. Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA, 1993. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol 15: 513-524.
25. Fruh K, Doumbo O, Muller H-M, Koita O, McBride J, Crisanti A, Toure Y, Bujard H, 1991. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect Immun 59: 1319-1327.
26. Rooth I, Perlmann YH, Bjorkman A, 1991. Plasmodium falciparum reinfection in children from a holoendemic area in relation to seroreactivities against oligopeptides from different malaria antigens. Am J Trop Med Hyg 45: 309-318.
27. Clerici M, DePalma L, Roilides E, Baker R, Shearer G, 1993. Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest 91: 2829-2836.